We investigated sex differences and the role of estrogen receptor-␤ (ER␤) on myocardial hypertrophy in a mouse model of pressure overload. We performed transverse aortic constriction (TAC) or sham surgery in male and female wild-type (WT) and ER␤ knockout (ER␤ Ϫ/Ϫ ) mice. All mice were characterized by echocardiography and hemodynamic measurements and were killed 9 wk after surgery. Left ventricular (LV) samples were analyzed by microarray profiling, real-time RT-PCR, and histology. After 9 wk, WT males showed more hypertrophy and heart failure signs than WT females. Notably, WT females developed a concentric form of hypertrophy, while males developed eccentric hypertrophy. ER␤ deletion augmented the TAC-induced increase in cardiomyocyte diameter in both sexes. Gene expression profiling revealed that WT male hearts had a stronger induction of matrix-related genes and a stronger repression of mitochondrial genes than WT female hearts. ER␤ Ϫ/Ϫ mice exhibited a different transcriptional response. ER␤ Ϫ/Ϫ /TAC mice of both sexes exhibited induction of proapoptotic genes with a stronger expression in ER␤ Ϫ/Ϫ males. Cardiac fibrosis was more pronounced in male WT/TAC than in female mice. This difference was abolished in ER␤ Ϫ/Ϫ mice. The number of apoptotic nuclei was increased in both sexes of ER␤ Ϫ/Ϫ / TAC mice, most prominent in males. Female sex offers protection against ventricular chamber dilation in the TAC model. Both female sex and ER␤ attenuate the development of fibrosis and apoptosis, thus slowing the progression to heart failure. heart failure MYOCARDIAL HYPERTROPHY is one of the most frequent causes of heart failure in humans, in a number of heart diseases, and is a negative prognostic sign itself. Myocardial hypertrophy is induced by different stimuli, such as pressure overload, hypertension, aging, diabetes, or myocardial ischemia. The development of myocardial hypertrophy is associated with alterations in cardiac geometry (size and shape) and is characteristically referred to as ventricular remodeling (31). In the early stage of pathologic cardiac hypertrophy frequently designated as adaptive response to stress, the heart walls thicken to compensate for the increased stress. In later stages, development of severe fibrosis impairs normal cardiac function and precedes a shift to decompensation with chamber dilatation, resulting in heart failure (10). Myocardial hypertrophy can be due to an increase in cardiomyocyte size as well as an increase in deposition of extracellular matrix components i.e., fibrosis. In the late stage, apoptosis of myocytes can also contribute to functional deterioration.
MYOCARDIAL HYPERTROPHY is one of the most frequent causes of heart failure in humans, in a number of heart diseases, and is a negative prognostic sign itself. Myocardial hypertrophy is induced by different stimuli, such as pressure overload, hypertension, aging, diabetes, or myocardial ischemia. The development of myocardial hypertrophy is associated with alterations in cardiac geometry (size and shape) and is characteristically referred to as ventricular remodeling (31) . In the early stage of pathologic cardiac hypertrophy frequently designated as adaptive response to stress, the heart walls thicken to compensate for the increased stress. In later stages, development of severe fibrosis impairs normal cardiac function and precedes a shift to decompensation with chamber dilatation, resulting in heart failure (10) . Myocardial hypertrophy can be due to an increase in cardiomyocyte size as well as an increase in deposition of extracellular matrix components i.e., fibrosis. In the late stage, apoptosis of myocytes can also contribute to functional deterioration.
In rodents, transverse aortic constriction (TAC) has been validated as a reproducible model to study the cardiac response to pressure overload. The TAC model is characterized by a first phase of compensated hypertrophy followed by a transition to heart failure and mimics human pressure overload-induced heart failure in a number of aspects. We chose this model to study hypertrophy and its transition to heart failure in wild-type (WT) and estrogen receptor-␤ (ER␤) knockout mice.
Sex differences in the manifestation of myocardial hypertrophy and the transition to heart failure have been described in patients with aortic stenosis (5) . In elderly patients with aortic stenosis and similar aortic pressure gradients in both sexes, women, have smaller ventricular volumes and a more concentric form of myocardial hypertrophy than men (3, 41) . Sexbased differences in myocardial morphology and function have also been described in animal models of pressure overload (9, 42) . Skavdahl et al. (38) reported that male mice exhibit a significantly higher increase in heart weight-to-body weight ratio than females 2 wk after TAC. The authors did not specify the form of hypertrophy, i.e., concentric or eccentric (38) . In the TAC model, myocardial hypertrophy develops after 2-4 wk, and the ejection fraction decreases after 8 -16 wk, depending on the imposed pressure gradient. So far, mainly short-term animal studies of up to 2 wk (32, 38) and only a few long-term animal studies (23, 40) have been performed. Consequently the onset of heart failure has not been studied in detail in this model. Although there have been a number of animal studies investigating myocardial hypertrophy, any sex differences involved have not been explicitly addressed.
Sex differences in the cardiovascular system have largely been attributed to the effects of sex steroid hormones, such as estrogen (E2), which are mainly mediated by their nuclear receptors, ER␣ and ER␤. The presence and the functionality of both receptors have been described in the human and rodent heart (12) . E2 receptors act as transcription factors, in a ligand-dependent manner and bind as hetero-or homodimer to hormone-responsive DNA elements after the recruitment of coactivators and corepressors that modify E2-mediated transcription. ER-mediated transcription can also be driven by ligand-independent mechanisms, e.g., phosphorylation, reviewed by Lannigan et al. (21) . In addition, ER␣ and ER␤ interact with cytosolic signaling (36) . ER␣ and ER␤ differ in their physiological function, as indicated by their specific expression pattern and the distinct phenotypes observed in ER␣ and ER␤ knockout mice, and also in their ligand specificities (44) . Some phytoestrogens, such as coumesterol, apigenin, and genistein compete with E2 stronger for binding to ER␤ than to ER␣ (20) . Pharmological approaches developed selective E2 receptor modulators, such as raloxifen and diarylpropiolnitrile, which bind with higher affinity to ER␤ (18) .
Both ER␣ and ER␤ are upregulated in the myocardium of patients with aortic stenosis (28) . Although the increase of ER␣ was similar in both sexes, the induction of ER␤ was stronger in female than in male hearts. This supports the role of ER␤ in myocardial adaptation.
In animal experiments, evidence for a dominant and cardioprotective role of ER␤ in the cardiac response to pressure load has been reported (2, 34, 38) . Deletion of ER␤ (ER␤ Ϫ/Ϫ ) in a mouse model of pressure overload led to a strong increase of myocardial hypertrophy in female but not in male mice (38) . Another study with ovariectomized WT and ER␤ Ϫ/Ϫ female mice showed an increase of myocardial hypertrophy 4 wk after TAC independent of genotype (2). The absence of ER␤ did not affect the hypertrophic response to 4 wk of pressure overload. This result might be due to the lack of circulating E2 in the ovariectomized mice and suggests that the effects of ER␤ on the development of cardiac hypertrophy and the maintenance of cardiac function depend on current hormone levels.
We hypothesized that sex differences appear in the late cardiac response to pressure overload and that the presence or absence of ER␤ would modify sex differences in myocardial and myocyte hypertrophy, contractile function, fibrosis, and apoptosis. To generate further hypotheses on the mechanisms that might drive the development of hypertrophy and heart failure, we analyzed LV samples by microarray assays for global gene expression changes.
METHODS

Materials.
All chemicals were purchased from Sigma and Invitrogen and real-time RT-PCR reagents were obtained from Applied Biosystems.
Animals and study design. Male and female WT and ER␤ Ϫ/Ϫ mice with the C57Bl/6J background (19) were used. We included 12 female and 12 male WT and ER␤ Ϫ/Ϫ mice for sham surgery. TAC intervention was done in 18 animals per group of male and female WT and ER␤ Ϫ/Ϫ mice (cohort 1). Transverse aortic constriction. The mice were anesthetized with ketamine hydrochloride (80 mg/ml)/xylazine hydrochloride (12 mg/ml) solution administered by intraperitoneal injection at a dose of 1 mg/kg. Animals were placed in the supine position under a dissecting stereoscope. Briefly, after induction of anesthesia, the mice were intubated and artificially ventilated (respirator: Hugo Basile model 7025; FMI). After sternotomy, the aorta and carotid arteries were exposed, and the transverse aorta was ligated by tying a 6-0 silk suture (FST) against a 26-gauge needle. The needle was then removed, leaving a narrowing of 0.4 mm in diameter. Sham animals underwent an identical surgical procedure without placement of the suture. Animals recovered from anesthesia under warming conditions and normal ventilation. Mice were killed 63 days after TAC or sham surgery.
Echocardiographic and hemodynamic measurements. Echocardiography (35) was performed after 2, 3, 4, 6, and 9 wk, and hemodynamic measurements were performed in 80 additionally operated mice (cohort 2) 9 wk post-TAC or sham surgery. Detailed protocols are described in the supplemental data for this article available online at the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology website. The mice were kept on a 12:12-h light-dark cycle in temperature-controlled rooms and were fed with commercial standard chow (Ssniff, Soest, Germany) and water ad libitum. All animal procedures were performed in accordance with the guidelines of the Charité Medical University Berlin and were approved by the Landesamt für Gesundheit und Soziales (LaGeSo, Berlin, Germany) for the use of laboratory animals (G0084/05) and followed the "Principles of Laboratory Animal Care" (NIH publication No. 86-23, revised 1985), as well as the current version of the German Law on the Protection of Animals.
After 9 wk, hearts were harvested, and isolated ventricles were immediately snap frozen in liquid nitrogen and stored at Ϫ80°C until use for genomic and proteomic assays (cohort 1). After completion of the hemodynamic measurements (cohort 2), hearts were fixed in 4% formaldehyde and stored until use for histological analyses.
Microarray analysis. (39) .
The interaction of the sex and hypertrophy was tested independently in the two genotypes. For the identification of differentially expressed genes in the comparison of four conditions in a given genotype, we used a two-way ANOVA to test for the interaction between hypertrophy (TAC/sham) and sex (male/female) without correction for multiple testing. For functional annotation and pathway analysis, we classified the genes as relatively upregulated in females or males, respectively. For example, a relative upregulation in females would correspond to: first, a relatively stronger induction (female-TAC/female-sham Ͼ male-TAC/male-sham Ͼ 1); second, a weaker repression (1 Ͼ female-TAC/female-sham Ͼ male-TAC/male-sham); or third, an opposite regulation (female-TAC/female-sham Ͼ 1 Ͼ male-TAC/male-sham) of gene expression.
For the detection of gene ontology (www.geneontology.org) categories and KEGG pathways (Kyoto Encyclopaedia of Genes and Genomes, www.kegg.com) with a significant overrepresentation of genes in a given group compared with the whole genome, the web-based DAVID (Database for Annotation Visualization and Integrated Discovery, National Institute of Allergy and Infectious Disease) tool was used (7, 16) .
Histology. Paraffin-embedded tissues were cut in 2-m sections. Hematoxylin/eosin staining to determine cardiomyocyte diameter and Sirius Red staining were used for fibrosis calculation. The cardiomyocyte diameter was calculated taking 15 pictures of each section and measuring the cardiomyocyte diameter of 50 cardiomyocytes/picture. The fibrosis score was calculated as following: (fibrotic area/total picture area) ϫ 100. Apoptotic nuclei were measured by using terminal deoxyneucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay (Flourescein FragEL DNA Fragmentation Detection Kit-Chemicon); nuclei were counterstained with 4,6-diamidino-2-phenylindole. Twenty pictures of each section were taken with a ϫ200 magnification. An apoptotic index was calculated as follows: 100 ϫ (total number of apoptotic nuclei/total number of nuclei). Stained sections were quantified using AxioVision Rel.4.6 (Zeiss) and ImageJ 1.38 ϫ software.
Data analysis and statistics. All data are expressed as means Ϯ SE and were tested for normal distribution. Data were analyzed for sex and treatment separately in the two genotypes and, in addition, to test this data set for sex and genotype, the ratios between all TAC groups and their controls were tested by two-way ANOVA and a post hoc Tukey's honestly significant difference test with Bonferroni correction by using SPSS 15.0 for Windows. Additionally, analyses of interaction were performed for all subgroups. P values Յ 0.05 were defined as statistically significant.
RESULTS
Modulation of cardiac hypertrophy and function by the sex and ER␤.
Chronic pressure overload of 9 wk led to an increase in the wall thickness of the myocardium and LV diameter in WT mice of both sexes; however, this increase was more pronounced in males. Accordingly, there was a significantly greater increase in LV mass (LVM) in male than in female WT mice after TAC (Fig. 1A, Table 1 ). LV ejection fraction decreased to similar levels in WT males and females following TAC surgery (Fig. 1B, Table 1 ). LV systolic (dp/dt max ) and Fig. 1 . Characterization of myocardial hypertrophy. A: left ventricular mass-to-tibia length ratio (LVM/TL) is significantly increased 9 wk after transverse aortic constriction (TAC) surgery after induction of pressure overload. The development of hypertrophy is sex dependent. Wild-type (WT) male (M) mice develop a higher degree of hypertrophy than female (F) mice. In estrogen receptor-␤ knockout (ER␤ Ϫ/Ϫ ) mice, LVM/TL was significantly increased 9 wk after TAC surgery in both sexes. Sex differences in the development of hypertrophy were not observed in ER␤ Ϫ/Ϫ mice. B and C: time course of ejection fraction (EF) in WT (B) and ER␤ Ϫ/Ϫ mice (C). After 9 wk, EF decreases in WT and ER␤ Ϫ/Ϫ /TAC-operated mice without sex differences in systolic function (B and C). The strongest decrease was observed in TACoperated ER␤ Ϫ/Ϫ males. The sham-operated ER␤ Ϫ/Ϫ males showed a decreased EF compared with sham-operated WT males (C). D: cardiomyocyte diameter 9 wk postsurgery. Increase of cardiomyocyte diameter following pressure overload was sex dependent in WT mice. The observed sex difference was abolished in the ER␤ Ϫ/Ϫ mice. Significances are defined as follows: *P Յ 0.05 or **P Յ 0.01 for the effect of TAC surgery (TAC vs. sham); #P Յ 0.05 or ##P Յ 0.01 for the sex effect (female vs. male), §P Յ 0.05 for the genotype effect; n.s., not significant. diastolic pressure (dp/dt min ) significantly increased similarly in both sexes after TAC (Table 1) . LV end-diastolic pressure (LVEDP) increased significantly in WT males but not in WT females. Wet lung weights increased only in WT males after TAC (Table 1) . Both parameters indicate greater pulmonary congestion and suggest more LV diastolic dysfunction in males than in females.
In ER␤ Ϫ/Ϫ mice, the development of LV hypertrophy (LVH) was similar between males and females (Fig. 1A , Table  1 ). Female ER␤ Ϫ/Ϫ /TAC mice developed more pronounced posterior wall thickness and relative wall thickness than males (Table 1) . Relative wall thickness is an indicator of concentric hypertrophy. Relative wall thickness did not differ significantly between the two sexes in WT hearts but became significantly different in ER␤ Ϫ/Ϫ mice. Indeed, ER␤ deletion led to a greater degree of concentric LVH in female mice ( Table 1) .
Deletion of ER␤ did not significantly modify the decrease in ejection fraction after TAC (Table 1 , Fig. 1, B and C) . However, ER␤ Ϫ/Ϫ /TAC male mice exhibited the most severely depressed ejection fraction among all groups. In addition, ER␤ Ϫ/Ϫ sham-operated males had a lower ejection fraction (40%) than sham-operated females (55%) or any other shamoperated group (P Յ 0.05); (Table 1, Fig. 1, B and C) . Thus, ER␤ seems to contribute to the maintenance of ejection fraction in male hearts. ER␤ did not significantly modify diastolic function, as estimated from LVEDP and lung weight ( Table 1) . The transaortic pressure gradient ranged between 48 -57 mmHg among all TAC groups. Heart rates were similar in all groups under basal conditions and after induction of pressure overload (Table. 1) .
Modulation of myocyte hypertrophy by the sex and ER␤. A significant increase in cardiomyocyte diameter occurred in WT male mice after TAC, while the observed increase in WT females did not reach statistical significance (Fig. 1D) . This is in agreement with the stronger development of LVH in the WT male hearts after TAC (Fig. 1A) . In ER␤ Ϫ/Ϫ mice, TAC caused a similar increase in cardiomyocyte diameter in both sexes. ER␤ Ϫ/Ϫ mice developed even stronger myocyte hypertrophy than WT mice in both sexes (P Յ 0.05), (Fig. 1D) . Thus, ER␤ deletion led to a more pronounced myocyte hypertrophy in both sexes.
Pressure overload induced sex-and genotype-dependent gene expression profiles. We used DNA microarrays to analyze the effect of TAC on global gene expression in independent comparisons separately in the two sexes and genotypes (e.g., WT/TAC female vs. WT sham female). Gene expression of alpha skeletal actin, natriuretic peptide precursor A, natriuretic peptide precursor B, procollagen type I, and connective tissue growth factor was induced significantly and to a similar degree in both sexes and genotypes (Supplemental Fig. IIA) . A small group of genes showed differential expression between males and females (Supplemental Fig. IIB ) independent of TAC and genotype (all males vs. all females). As in previous studies for somatic tissues (37) , the overall number of sex specifically regulated genes was relatively low (14 genes, fold change Ͼ1.5 and false discovery rate Ͻ5%, SAM). Six genes showed higher expression in females including several X-linked genes. Eight genes showed higher expression in males including members of the X-degenerated region of the Y chromosome (Supplemental Fig. IIB) . In WT mice, 702 genes were responsive to pressure overload in females and 1,352 genes in males (fold change Ͼ1.5 and false discovery rate Ͻ5%, SAM) (Supplemental Fig. I ). In ER␤ Ϫ/Ϫ mice, 835 genes were responsive to pressure overload in females and 3,505 genes in males (Supplemental Fig. I) .
Functional classification of sex and pressure overload-regulated genes in the two genotypes. We first assessed the effect of the interaction of TAC and sex independently in both genotypes, by calculating the P value for the interaction (ANOVA). In WT mice TAC-induced pressure overload led to the differential regulation of 856 genes in females and males (P Ͻ 0.05). Of these, 338 genes showed a relative upregulation Values are means Ϯ SE. All measurements were performed after 9 wk post-sham/TAC surgery. WT, wild type; ER␤Ϫ/Ϫ, estrogen receptor-␤ knockout; LVM, left ventricular (LV) mass; LVM/TL, LVmass/tibia length; LVIDd, LV internal diameter during diastole; LVIDs, LV internal diameter during systole; PWd, posterior wall thickness during diastole; IVSs, septum thickness during diastole; TH/r, relative wall thickness; EF, ejection fraction; TPG, transaortic pressure gradient; Dp/dtmax and Dp/dtmin, first derivative of left ventricular (LV) pressure over time at maximum and minimum; LVEDP, LV end-diastolic pressure; LW, lung weight; HR, heart rate.
a P Յ 0.05 or b P Յ 0.01 for the effect of TAC surgery (TAC vs. sham); c P Յ 0.05 or d P Յ 0.01 for the sex effect (female versus male); e P Յ 0.05 for the genotype effect.
in females, which could be due to a relatively stronger induction or to a weaker repression in females or an opposite regulation in males. These genes are designated female specific. Vice versa, 518 genes showed a relative upregulation in males and are designated male-specific (Supplemental Fig. I ).
In ER␤ Ϫ/Ϫ mice, TAC-induced pressure overload led to the differential regulation of 832 genes in females and males (P Ͻ 0.05). Of these, 479 genes showed a relative upregulation in females, and vice versa, 353 genes showed a relative upregulation in males and are designated male-specific (Supplemental Fig. I) .
The following data analysis steps are based on these four sets of sex-specific regulated genes in the two genotypes. These genes were classified according to their Gene Ontology term and their presence in KEGG pathways with the internetbased DAVID program. Categories and pathways with a significant enrichment of genes and a potential relevance for the development of hypertrophy are shown in Table 2 . In WT female mice, a relatively stronger expression of metabolic genes, e.g., oxidative phosphorylation (Table 2) was detected. Some genes of complex I (Ndufs4, Ndufs5), complex III (Qcr2, Qcr6), complex IV (Cox7A, Cox10), and of the ATP-synthetase were less downregulated in WT females than males. In contrast WT male mice showed a relatively stronger expression of MAPK signaling and regulation of the cytoskeleton (Table  2) . These pathways are related to genes, which belong to the extracellular matrix and lead, if activated, to the induction of fibroblast growth factors and renin-angiotensin system. A whole set of genes of growth factor signaling, including fibroblast-related growth, was upregulated exclusively in male WT mice (Supplemental Table II ). In ER␤ Ϫ/Ϫ mice, a different global sex and pressure overload-regulated gene expression pattern was observed (Table 2) . Female ER␤ Ϫ/Ϫ mice showed a relatively stronger expression of genes involved in ubiquitinmediated proteolysis, Wnt and p53 signaling ( Table 2) . Male ER␤ Ϫ/Ϫ mice showed a relatively stronger expression of genes that play a role in the regulation of programmed cell death (Supplemental Table III ), cell proliferation, and TGF signaling ( Table 2) .
Cardiac fibrosis is modified by the interaction of TAC, sex, and genotype. Since in the microarray analysis we observed the induction of fibrosis-related genes in males (Supplemental Table II ), we undertook further histological analyses for the assessment of fibrosis. In WT mice, only males showed a strong increase of fibrosis in the interstitium and perivascular areas of the myocardium (Fig. 2, A and C) . Female mice showed a higher degree of fibrosis than males in the basal state (Fig. 2, A and C) and less increase of fibrosis than males after TAC. This is in agreement with the microarray findings suggesting a stronger induction of matrix synthesis in males. The degree of fibrosis in male ER␤ Ϫ/Ϫ 9 wk after TAC was less pronounced than in male WT mice (Fig. 2, B and C) . In contrast, ER␤ Ϫ/Ϫ females developed more severe cardiac fibrosis than ER␤ Ϫ/Ϫ males and WT females. Collagen I and III gene expression determined to an earlier time point support our data on fibrosis development (data not shown). Here we could observe a similar expression pattern, which might have led to the observed fibrosis score. Thus, ER␤ deletion appears to limit fibrosis in male, and to induce fibrosis in female, hearts.
Loss of ER␤ induces apoptosis. Our genome-wide profiling revealed that apoptosis occurred in a sex-dependent manner. Therefore, we further investigated the extent of apoptosis by the TUNEL assay. On the one hand, we found only a few apoptotic cells in WT mice (Fig. 3A) after sham or TAC surgery without any sex-related differences (Fig. 3B) . On the other hand, in ER␤ Ϫ/Ϫ females we found a sixfold increase of apoptosis (P Ͻ 0.05). However, ER␤ Ϫ/Ϫ males showed a 100-fold (P Ͻ 0.01) increased induction of apoptosis (Fig. 3, A  and B) . Therefore, the loss of ER␤ promotes apoptosis in a sex-specific manner.
DISCUSSION
We show for the first time that sex differences in the development of LVH and heart failure following chronic pressure overload are related to different actions of ER␤ in both sexes. In WT mice, the development of myocardial hypertrophy is more pronounced in males than in females. This is associated with greater myocyte hypertrophy and more fibrosis in males. The deletion of ER␤ reduces these sex differences. Endogenous ER␤ acts differently in male and female hearts. While ER␤ promotes fibrosis in males, it inhibits fibrosis in female hearts. ER␤ limits cardiomyocyte hypertrophy and inhibits apoptosis in both sexes, but with a greater antiapoptotic effect in male hearts that develop more apoptosis per se. Thus, under pressure overload the loss of ER␤ is detrimental for both males and females.
Sex differences in myocardial hypertrophy. Sex differences in the prevalence and severity of cardiovascular disease have been reported in human clinical studies (15, 22) . The pathophysiology and function of the heart differs between men and women in pressure overload and heart failure (5). Among patients with aortic stenosis, women have a more concentric form of myocardial hypertrophy and better-preserved myocardial function than men (1, 3) . Among heart failure patients, women tend to develop heart failure with preserved systolic Fig. 3 . A: terminal deoxyneucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay of histological sections 9 wk after surgery. Detection of apoptotic nuclei (yellow arrows) with Tdt-enzyme labeled with FITC (green) and staining of nuclei with 4,6-diamidino-2-phenylindole (blue). B: digital analysis of the TUNEL assay; total number of apoptotic nuclei. Significances are: *P Յ 0.05, **P Յ 0.01. function, whereas men develop an eccentric form of hypertrophy with a loss of systolic function (1, 3) . These observations are in agreement with the morphological changes in our WT mice, which showed more concentric LVH in females and more eccentric LVH in males. Sexual dimorphism in cardiac remodeling after myocardial infarction has also been found in end-stage human ischemic cardiomyopathy. Heart weight index was significantly greater in men who also exhibited a larger myocyte volume (6), which we also observed in our study. However, the relationship between sex, hypertrophy, and heart failure is complex and appears to depend on the specific model employed, the age and the stage of hypertrophy or heart failure. Among other findings, significant sex differences in the proliferative response of cardiac fibroblasts under ischemic conditions to estrogens have been reported (11) .
Molecular mechanisms of sex differences in pressure overload. In our previous studies, gene expression was regulated in a sex-specific manner 2 wk after pressure overload in WT mice, despite the fact that sex differences in cardiac morphology and function did not occur at this early time point (43) . Female hearts responded to pressure overload with a better adaptation in cardiac energy metabolism. Genes encoding for mitochondrial function and fatty acid oxidation were less downregulated in female hearts, while in males a relative upregulation of matrix remodeling and ribosomal genes was identified. These processes that we observed in the early stage of hypertrophy may represent the molecular basis for the sex-specific functional changes observed at late stages of pressure overload and LVH. In the present study, we found functional differences between the sexes in accordance with similar molecular changes. Nine weeks after TAC, WT females still exhibited a better maintenance of cardiac energy metabolism, since genes encoding for mitochondrial function, i.e., oxidative phosphorylation, were less suppressed in WT females than in males. In agreement with our previous findings, WT males exhibited a relative upregulation of genes involved in matrix remodeling and cell proliferation. Histological quantification of fibrosis and apoptosis is fully in agreement with these microarray data. Changes in the transcriptome do not only support the histological but also the functional analysis.
The findings may even apply to the human heart. Gene expression profiling in patients with idiopathic dilated cardiomyopathy revealed a sex-specific gene expression pattern (14) . In female patients, mostly metabolic genes were deregulated and genes related to muscle contraction and extracellular matrix in males.
Role of ER␤ on global gene expression, myocardial hypertrophy, and fibrosis. A major role for ER␤ was indicated by the different global gene expression profile in ER␤
Ϫ/Ϫ mice. This profile does not necessarily require the presence of ER␤ in the heart. Activation of IGF/Akt signaling by central ER could be sufficient to transmit such an effect. Both cardiac myocytes and fibroblasts express functional ERs (12) , and E2 modulates cardiac growth via myocyte receptors (8) . Our own experiments in human heart also show an upregulation of both ERs in aortic stenosis hearts, with a prominent upregulation of ER␤ particularly in female hearts (28) . This supports the role of myocardial ER␤ in cardiac adaptation. In ER␤ Ϫ/Ϫ females, we observed a switch in the compensation of pressure overload compared with WT hearts. Genes involved in ubiquitin-mediated proteolysis and Wnt signaling were specifically induced. Male ER␤ Ϫ/Ϫ mice showed a relatively stronger expression of genes that play a role in the regulation of cell proliferation and programmed cell death. These different gene expression profiles observed in the ER␤ Ϫ/Ϫ mice may contribute to the enhanced LVH and the accelerated transition to heart failure in both sexes.
A number of animal studies support the antihypertrophic effect of estrogens in the myocardium. E2 treatment of ovariectomized female mice caused a reduction of 30% in pressure overload-induced LVH (40) . In agreement with these studies (2, 34, 38) , our findings that ER deletion increases cardiomyocyte hypertrophy indicate that ER␤ mediates antihypertrophic effects of endogenous E2 in chronic pressure overload. Pedram et al. demonstrated that E2 exerts its positive effects via ER␤ (34) . E2 replacement in female animals inhibited interstitial fibrosis, which was mediated by ER␤. This is well in agreement with the antifibrotic effects of ER␤ in our female hearts. So far, most previous work on the cardiac effects of E2 and ER focused on the analysis of just one sex. Comparisons of the effects of ER stimulation between male and female animals are rare. We now report the novel finding that ER␤ influences cardiac remodeling by limiting cardiac fibrosis, apoptosis, and the development of LVH in a sex-dependent manner. This will need certainly further exploration.
Sex differences in myocyte cell death. A role for apoptosis has been described in a number of clinical and animal studies of aging and cardiac diseases, including chronic myocardial hypertrophy and heart failure (25, 26, 29) . In the failing human heart, cardiomyocyte apoptosis was significantly different between men and women (13, 30) . Cardiomyocyte death was markedly lower in women than in men. The higher rate of Sex and ER␤ influence the progression from hypertrophy toward heart failure (HF) based on previous (43) and present data. After 9 wk of chronic pressure overload, female WT mice have a better metabolic adaptation than male mice; at that time point, male WT mice develop more fibrosis. The deletion of ER␤ has detrimental effects on the progression of heart failure and leads to more fibrosis in females and to apoptosis in males.
apoptosis was associated with a shorter duration of myopathy and an earlier onset of heart failure. Experimentally, myocyte apoptosis has been implicated in the transition from compensated to decompensated cardiac hypertrophy (24) . However, sex differences and the involvement of ER␤ in apoptotic processes have not yet been investigated. In our setting, apoptosis occurred predominantly in male ER␤ Ϫ/Ϫ mice, indicating that ER␤ limited apoptosis in the WT mice. The sex differences in apoptosis might be due to different endogenous levels of E2 between the sexes. This is well in agreement with recent data in vivo and in vitro showing that E2-treatment inhibits apoptosis only in females after myocardial infarction (33) . We suggest that ER␤ might also mediate these antiapoptotic effects of endogenous E2 and that this action could contribute to a different regulation of apoptosis among the sexes.
Conclusion. This study shows for the first time, that the effects of ER␤ on cardiac remodeling differ in female and male mice exposed to pressure overload. We hypothesize that females have a better adaptation of myocardial energy metabolism and develop less apoptosis and fibrosis than males under pressure overload (Fig. 4) . ER␤ limits the development of cardiac hypertrophy in females and males by different mechanisms. In female mice, ER␤ predominantly contributes to the maintenance of energy homeostasis and limits the development of eccentric cardiac hypertrophy and fibrosis. In contrast, in males, ER␤ restricts cardiomyocyte hypertrophy and induction of apoptosis. This may influence the progression to heart failure in later stages in a sex-specific manner.
Perspectives and Significance
E2 has not evolved as a therapeutic option for either women or men. Based on our studies, ER␤-targeted drugs might have a place in prevention and treatment of heart disease.
